Market Cap: $39.85B
Market Cap: $39.85B
Open
$9.76
Prev. Close
$9.20
High
$9.80
Low
$9.62
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region.
Haleon plc trades on the New York Stock Exchange under the ticker HLN, priced in USD.
Haleon plc has a market capitalisation of $39.85B, based on its latest share price.
HLN trades at 18.87 times its trailing 12-month earnings.
Over the past 52 weeks HLN has traded between $8.38 and $11.28.
Yes. Haleon plc's dividend yields 2.13% at the current share price, paying out 39% of its earnings.
Profitable, with a net margin of 14.6% over the last 12 months.
The analyst consensus rating for HLN is Buy.
Brian James McNamara is the CEO of Haleon plc, which is headquartered in Weybridge.
Generated automatically from reported financial data. General information only, not financial advice.
TUMS Launches Fantasy Foodball Pool to Enhance Gameday Experience In a creative partnership with DraftKings, TUMS introduces the TUMS Fantasy Foodball Pool, a free online game that caters to food enth…
Haleon Strengthens Leadership with New CCO Appointment Haleon plc, a prominent player in the consumer health sector, announces the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its…
Haleon Appoints Joe Sta-Romana as Chief Customer Officer to Drive Growth in U.S. Market Haleon plc, a prominent consumer health company, announces the appointment of Joe Sta-Romana as its new Chief Cu…